Fund
Alexandria Venture Investments
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 3
- Lead
- 0
- New entries
- 2
- Follow ons
- 1
- Latest operation
- 24 September 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 24 Sept | United States, Biotech | Series C | 75 M$ | Existing investor |
| 17 Aug | United States, Biotech | Series A | 30 M$ | Participant |
| 13 Aug | United States, Biotech | Series B | 50 M$ | Participant |
Co investors 23 funds crossed
- Eli Lilly and Company 2 operations
- 8VC 1 operation
- Amgen Ventures 1 operation
- Andreessen Horowitz 1 operation
- Catalio Capital Management 1 operation
- Chugai Venture Fund 1 operation
- DFJ Growth 1 operation
- Discovery Ventures 1 operation
- Euclidean Capital 1 operation
- Forge Life Science Partners 1 operation
- GRIDS Capital 1 operation
- Intermountain Ventures 1 operation
- LG Technology Ventures 1 operation
- Longwood Fund 1 operation
- Merck Global Health Innovation Fund 1 operation
- Newpath Partners 1 operation
- OrbiMed 1 operation
- PhiFund 1 operation
- Premji Invest 1 operation
- Quadrille Capital 1 operation
- S32 1 operation
- Sigmas Group 1 operation
- SV Health Investors Dementia Discovery Fund 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.